Source: Annual Congress 2002 - Asthma: animal models
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. K. Ikeda, D. H. Broide (La Jolla, United States Of America). Resolution of inflammation in a mouse model of acute asthma: comparison of cpg dna and corticosteroids. Eur Respir J 2002; 20: Suppl. 38, 3522

Member's Comments

No comment yet.

Related content which might interest you: Steroid-resistant inflammation in a mouse model of severe asthma is not inhibited by the combination of theophylline and budesonide Source: International Congress 2018 – Basic pharmacology Year: 2018 Roflumilast but not dexamethasone or fluticasone reduces neutrophilic airway inflammation and hyperreactivity in a murine influenza-induced asthma exacerbation model Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Development of a novel prediction model for acute asthma exacerbation Source: International Congress 2018 – Asthma management Year: 2018 Photobiomodulation and corticosteroid modulate pulmonary inflammation and airway reactivity in an experimental model of chronic asthma Source: International Congress 2018 – Basic pharmacology Year: 2018 Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 360s Year: 2007 Severe asthma: from inflammatory phenotype to treatment Source: International Congress 2017 – Chinese Programme 2017 Year: 2017 Development of a mouse model of airway inflammation and remodeling in experimental asthma Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007 Targeting PI3Kd attenuates influenza virus-induced inflammation in a murine model of asthma exacerbation Source: International Congress 2017 – Infection and exacerbation science Year: 2017 Conclusion: clinical phenotypes of asthma Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005 Characterisation of a chronic pre-clinical model of allergic asthma Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Models of asthma employing ovalbumin in rats and mice: similarities and differences compared with patient asthma Source: Annual Congress 2005 - PG11 - Experimental models for COPD and asthma Year: 2005 Azithromycin exhibits interferon-inducing properties in an experimental mouse model of asthma exacerbation Source: International Congress 2015 – Asthma mechanisms and management Year: 2015 Sirtuin3 reduces acute lung inflammation and emphysematous aggravation in COPD exacerbation mouse model Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency Year: 2019 Treatment with gp120 reduces AHR and airway inflammation in a humanized mouse model of asthma bronchiale Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 Comparison of the inflammatory response between two chronic models of allergic lung inflammation Source: Eur Respir J 2007; 30: Suppl. 51, 368s Year: 2007 LSC 2010 Abstract: Synthetic dsRNA exacerbates pulmonary inflammation in acute and sub-chronic in vivo models of COPD Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Corticosteroids prevent airway remodeling in a mouse model of chronic asthma through TGF-β signaling Source: Eur Respir J 2006; 28: Suppl. 50, 225s Year: 2006 Regular and moderate exercise prevents airway remodeling in a murine model of chronic allergic asthma Source: Annual Congress 2011 - Physiological basis of respiratory disease Year: 2011 Alamandine reduces eosinophilic inflammation in an experimental model of asthma Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD Year: 2018 Single versus multiple challenge in a mouse model of chemical-induced asthma Source: Eur Respir J 2005; 26: Suppl. 49, 587s Year: 2005